Ditchcarbon
  • Contact
  1. Organizations
  2. Esteve Pharmaceuticals, S.A.
Public Profile
Pharmaceutical Preparation Manufacturing
ES
updated 7 days ago

Esteve Pharmaceuticals, S.A.

Company website

Esteve Pharmaceuticals, S.A., commonly known as Esteve, is a prominent player in the global pharmaceutical industry, headquartered in Barcelona, Spain. Founded in 1929, Esteve has established itself as a leader in the development of innovative medicines, particularly in the fields of pain management, respiratory diseases, and central nervous system disorders. With a strong presence in Europe and Latin America, Esteve is recognised for its commitment to research and development, resulting in a diverse portfolio of unique products and services. The company’s dedication to quality and innovation has earned it a solid market position, marked by notable achievements in both therapeutic advancements and strategic partnerships. Esteve continues to focus on enhancing patient care through its specialised offerings, making it a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Esteve Pharmaceuticals, S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

48

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Esteve Pharmaceuticals, S.A.'s score of 48 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

67%

Let us know if this data was useful to you

Esteve Pharmaceuticals, S.A.'s reported carbon emissions

In 2024, Esteve Pharmaceuticals, S.A. reported total carbon emissions of approximately 274,764,000 kg CO2e. This figure includes 12,182,000 kg CO2e from Scope 1 emissions, 16,755,000 kg CO2e from Scope 2 emissions, and a significant 262,425,000 kg CO2e from Scope 3 emissions. This represents a reduction of about 10.41% in total emissions compared to the base year of 2022, reflecting the effectiveness of their emission reduction strategies. In 2023, the company recorded total emissions of approximately 290,708,000 kg CO2e, with Scope 1 emissions at 11,494,000 kg CO2e, Scope 2 at 17,660,000 kg CO2e, and Scope 3 at 279,037,000 kg CO2e. The trend shows a decrease in emissions over the years, as 2022 emissions were approximately 306,707,000 kg CO2e, with Scope 1 at 9,553,000 kg CO2e, Scope 2 at 15,671,000 kg CO2e, and Scope 3 at 281,481,000 kg CO2e. Esteve Pharmaceuticals has not reported any Science-Based Targets Initiative (SBTi) targets but has committed to reducing its emissions through various strategies. The company’s climate commitments are evident in their ongoing efforts to lower emissions across all scopes, particularly in Scope 3, which constitutes the majority of their carbon footprint.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20092010201120202021202220232024
Scope 1
9,982,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
00,000,000
00,000,000
Scope 2
16,014,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
11,963,000
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Esteve Pharmaceuticals, S.A.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Esteve Pharmaceuticals, S.A. is in ES, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Esteve Pharmaceuticals, S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Chiesi Farmaceutici

IT
•
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Diocle S.p.A.

IT
•
Real estate services (70)
Updated 24 days ago

Ipsen

FR
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy